NO992186L - System med forsinket avlevering for syresensitive medikamenter - Google Patents
System med forsinket avlevering for syresensitive medikamenterInfo
- Publication number
- NO992186L NO992186L NO992186A NO992186A NO992186L NO 992186 L NO992186 L NO 992186L NO 992186 A NO992186 A NO 992186A NO 992186 A NO992186 A NO 992186A NO 992186 L NO992186 L NO 992186L
- Authority
- NO
- Norway
- Prior art keywords
- delivery system
- acid
- barrier
- omeprazole
- pulsatile
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74098196A | 1996-11-06 | 1996-11-06 | |
PCT/US1997/020851 WO1998019668A1 (en) | 1996-11-06 | 1997-11-05 | Delayed delivery system for acid-sensitive drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992186L true NO992186L (no) | 1999-05-05 |
NO992186D0 NO992186D0 (no) | 1999-05-05 |
Family
ID=24978866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992186A NO992186D0 (no) | 1996-11-06 | 1999-05-05 | System med forsinket avlevering for syresensitive medikamenter |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0941074B1 (de) |
AT (1) | ATE271379T1 (de) |
AU (1) | AU5179898A (de) |
DE (1) | DE69729950T2 (de) |
NO (1) | NO992186D0 (de) |
WO (1) | WO1998019668A1 (de) |
ZA (1) | ZA979937B (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2774288B1 (fr) | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
FR2793688B1 (fr) | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
SE9902386D0 (sv) * | 1999-06-22 | 1999-06-22 | Astra Ab | New formulation |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
DE19959419A1 (de) | 1999-12-09 | 2001-06-21 | Ratiopharm Gmbh | Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung |
ATE297194T1 (de) * | 1999-12-16 | 2005-06-15 | Medinfar Produtos Farmaceutico | Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate |
US6500457B1 (en) * | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
ES2663873T3 (es) * | 2001-10-29 | 2018-04-17 | Massachusetts Institute Of Technology | Forma farmacéutica con perfil de liberación de orden cero fabricada por impresión tridimensional |
US8168170B2 (en) | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
WO2004080439A1 (ja) * | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | 高濃度に活性成分を球形核に付着させた医薬組成物 |
WO2005051362A2 (en) * | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
CN1964704A (zh) * | 2004-03-03 | 2007-05-16 | 特瓦制药工业有限公司 | 包含酸不稳定药物的稳定药用组合物 |
EP1755566A2 (de) * | 2004-06-15 | 2007-02-28 | Teva Pharmaceutical Industries Ltd | Stabile pharmazeutische formulierungen von benzimidazolverbindungen |
AR052225A1 (es) * | 2004-11-04 | 2007-03-07 | Astrazeneca Ab | Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones |
AR051654A1 (es) * | 2004-11-04 | 2007-01-31 | Astrazeneca Ab | Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones |
PL1912650T3 (pl) | 2005-08-03 | 2018-01-31 | Sprout Pharmaceuticals Inc | Zastosowanie flibanseryny w leczeniu otyłości |
WO2007048803A1 (en) | 2005-10-29 | 2007-05-03 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20090104264A1 (en) * | 2005-12-28 | 2009-04-23 | Takeda Pharmaceutical Company Limited | Controlled release solid preparation |
EP1967183A4 (de) * | 2005-12-28 | 2011-02-23 | Takeda Pharmaceutical | Feststoffpräparat mit kontrollierter freisetzung |
US20090312242A1 (en) | 2006-06-30 | 2009-12-17 | Ramiro Castro | Flibanserin for the treatment of urinary incontinence and related diseases |
AR062320A1 (es) | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
CN104721168A (zh) * | 2006-08-25 | 2015-06-24 | 贝林格尔·英格海姆国际有限公司 | 控制释放系统及其制造方法 |
CN101711158A (zh) | 2007-02-01 | 2010-05-19 | 爱默思公司 | 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法 |
UY31335A1 (es) | 2007-09-12 | 2009-04-30 | Tratamiento de sintomas vasomotores | |
WO2009113090A2 (en) * | 2008-01-17 | 2009-09-17 | Alkem Laboratories Ltd. | Process for preparing an oral formulation of an acid-sensitive benzimidazole drug |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
CZ289804B6 (cs) * | 1994-07-08 | 2002-04-17 | Astrazeneca Ab | Multijednotková tabletovaná dávková forma I |
-
1997
- 1997-11-05 ZA ZA979937A patent/ZA979937B/xx unknown
- 1997-11-05 EP EP97946676A patent/EP0941074B1/de not_active Expired - Lifetime
- 1997-11-05 WO PCT/US1997/020851 patent/WO1998019668A1/en active IP Right Grant
- 1997-11-05 AU AU51798/98A patent/AU5179898A/en not_active Abandoned
- 1997-11-05 DE DE69729950T patent/DE69729950T2/de not_active Expired - Fee Related
- 1997-11-05 AT AT97946676T patent/ATE271379T1/de not_active IP Right Cessation
-
1999
- 1999-05-05 NO NO992186A patent/NO992186D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69729950D1 (de) | 2004-08-26 |
ZA979937B (en) | 1999-05-18 |
EP0941074B1 (de) | 2004-07-21 |
EP0941074A1 (de) | 1999-09-15 |
ATE271379T1 (de) | 2004-08-15 |
WO1998019668A1 (en) | 1998-05-14 |
NO992186D0 (no) | 1999-05-05 |
AU5179898A (en) | 1998-05-29 |
DE69729950T2 (de) | 2005-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992186D0 (no) | System med forsinket avlevering for syresensitive medikamenter | |
KR101078636B1 (ko) | 약학 활성원의 지연 및 조절된 방출을 위한 생약 미세입자구강 제제 | |
AU1488295A (en) | Pharmaceutical composition | |
DE60021604D1 (de) | Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben | |
NO982302L (no) | Farmas°ytisk sammensetning | |
PT1117386E (pt) | Administracao enterica e colonica utilizando capsulas de hpmc | |
NZ237516A (en) | Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release | |
MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
NO20003640L (no) | Ny doseringsform | |
RU99126869A (ru) | Фармацевтический препарат омепразола | |
IT1246382B (it) | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon | |
NZ711298A (en) | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents | |
DK0754452T3 (da) | Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet | |
US5824341A (en) | Composition providing selective release of an active ingredient | |
MXPA05001243A (es) | Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion. | |
WO2001024777A1 (en) | Coated solid dosage forms | |
KR20220113697A (ko) | 알칼리제 및 장용성 코팅층을 포함하는 투여 형태 | |
AU736357B2 (en) | Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient | |
WO2001078681A1 (fr) | Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant | |
AU2009247712B2 (en) | Compositions and methods for inhibiting gastric acid secretion | |
US20060043207A1 (en) | Apparatus, kit and related methods for administering substances | |
US6074669A (en) | Controlled drug delivery system for diltiazem | |
AU2014239683A1 (en) | Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability | |
EP4013401A1 (de) | Gegenstände und verfahren zur verabreichung therapeutischer mittel | |
JPH06256166A (ja) | 薬物放出制御製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |